BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Slieker MG, Sanders EA, Rijkers GT, Ruven HJ, van der Ent CK. Disease modifying genes in cystic fibrosis. Journal of Cystic Fibrosis 2005;4:7-13. [DOI: 10.1016/j.jcf.2005.05.006] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Skopelja S, Hamilton BJ, Jones JD, Yang ML, Mamula M, Ashare A, Gifford AH, Rigby WF. The role for neutrophil extracellular traps in cystic fibrosis autoimmunity. JCI Insight 2016;1:e88912. [PMID: 27777975 DOI: 10.1172/jci.insight.88912] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 7.5] [Reference Citation Analysis]
2 Pierandrei S, Blaconà G, Fabrizzi B, Cimino G, Cirilli N, Caporelli N, Angeloni A, Cipolli M, Lucarelli M. Two novel and correlated CF-causing insertions in the (TG)mTn tract of the CFTR gene. PLoS One 2019;14:e0222838. [PMID: 31593572 DOI: 10.1371/journal.pone.0222838] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Carlsson M, Eriksson L, Pressler T, Kornfält R, Mared L, Meyer P, Wiik A, Wieslander J, Segelmark M. Autoantibody response to BPI predict disease severity and outcome in cystic fibrosis. J Cyst Fibros 2007;6:228-33. [PMID: 17166780 DOI: 10.1016/j.jcf.2006.10.005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
4 Wang X, Koulov AV, Kellner WA, Riordan JR, Balch WE. Chemical and biological folding contribute to temperature-sensitive DeltaF508 CFTR trafficking. Traffic 2008;9:1878-93. [PMID: 18764821 DOI: 10.1111/j.1600-0854.2008.00806.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 4.4] [Reference Citation Analysis]
5 de Lima Marson FA, Bertuzzo CS, Secolin R, Ribeiro AF, Ribeiro JD. Genetic interaction of GSH metabolic pathway genes in cystic fibrosis. BMC Med Genet 2013;14:60. [PMID: 23758905 DOI: 10.1186/1471-2350-14-60] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
6 Brazova J, Sismova K, Vavrova V, Bartosova J, Macek M Jr, Lauschman H, Sediva A. Polymorphisms of TGF-beta1 in cystic fibrosis patients. Clin Immunol 2006;121:350-7. [PMID: 17052957 DOI: 10.1016/j.clim.2006.08.015] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 1.8] [Reference Citation Analysis]
7 Lima CSP, Ortega MM, Marson FAL, Zulli R, Ribeiro AF, Bertuzzo CS. Mutações do gene cystic fibrosis transmembrane conductance regulator e deleções dos genes glutationa S-transferase em pacientes com fibrose cística no Brasil. J bras pneumol 2012;38:50-6. [DOI: 10.1590/s1806-37132012000100008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
8 Czerska K, Sobczynska-Tomaszewska A, Sands D, Nowakowska A, Bak D, Wertheim K, Poznanski J, Zielenski J, Norek A, Bal J. Prostaglandin-endoperoxide synthase genes COX1 and COX2 - novel modifiers of disease severity in cystic fibrosis patients. J Appl Genet 2010;51:323-30. [PMID: 20720307 DOI: 10.1007/BF03208862] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
9 Furlan LL, Marson FA, Ribeiro JD, Bertuzzo CS, Salomão Junior JB, Souza DR. IL8 gene as modifier of cystic fibrosis: unraveling the factors which influence clinical variability. Hum Genet 2016;135:881-94. [PMID: 27209008 DOI: 10.1007/s00439-016-1684-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
10 Yokoyama E, Chávez-Saldaña M, Orozco L, Cuevas F, Lezana JL, Vigueras-Villaseñor RM, Rojas-Castañeda JC, Landero DA. Influence of SNPs in Genes that Modulate Lung Disease Severity in a Group of Mexican Patients with Cystic Fibrosis. Arch Med Res 2018;49:18-26. [PMID: 29703608 DOI: 10.1016/j.arcmed.2018.04.010] [Reference Citation Analysis]
11 Kotnala S, Dhasmana A, Kashyap VK, Chauhan SC, Yallapu MM, Jaggi M. A bird eye view on cystic fibrosis: An underestimated multifaceted chronic disorder. Life Sci 2021;268:118959. [PMID: 33383045 DOI: 10.1016/j.lfs.2020.118959] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Chioccioli M, Feriani L, Kotar J, Bratcher PE, Cicuta P. Phenotyping ciliary dynamics and coordination in response to CFTR-modulators in Cystic Fibrosis respiratory epithelial cells. Nat Commun 2019;10:1763. [PMID: 30992452 DOI: 10.1038/s41467-019-09798-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
13 Mafficini A, Ortombina M, Sermet-Gaudelius I, Lebecque P, Leal T, Iansa P, Reychler G, Dahan K, Pepermans X, Lenoir G, Leonard A, Sorio C, Assael B, Melotti P. Impact of polymorphism of Multidrug Resistance-associated Protein 1 (ABCC1) gene on the severity of cystic fibrosis. J Cyst Fibros 2011;10:228-33. [PMID: 21435954 DOI: 10.1016/j.jcf.2010.10.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
14 Barrett KE. New ways of thinking about (and teaching about) intestinal epithelial function. Adv Physiol Educ. 2008;32:25-34. [PMID: 18334565 DOI: 10.1152/advan.00092.2007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
15 Lim SH, Legere EA, Snider J, Stagljar I. Recent Progress in CFTR Interactome Mapping and Its Importance for Cystic Fibrosis. Front Pharmacol 2017;8:997. [PMID: 29403380 DOI: 10.3389/fphar.2017.00997] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
16 Alibakhshi R, Kianishirazi R, Cassiman JJ, Zamani M, Cuppens H. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations. J Cyst Fibros 2008;7:102-9. [PMID: 17662673 DOI: 10.1016/j.jcf.2007.06.001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
17 Samuels ME. Saturation of the human phenome. Curr Genomics 2010;11:482-99. [PMID: 21532833 DOI: 10.2174/138920210793175886] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
18 Hillian AD, Londono D, Dunn JM, Goddard KA, Pace RG, Knowles MR, Drumm ML; CF Gene Modifier Study Group. Modulation of cystic fibrosis lung disease by variants in interleukin-8. Genes Immun 2008;9:501-8. [PMID: 18563170 DOI: 10.1038/gene.2008.42] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
19 Houwen RH, van der Doef HP, Sermet I, Munck A, Hauser B, Walkowiak J, Robberecht E, Colombo C, Sinaasappel M, Wilschanski M. Defining DIOS and Constipation in Cystic Fibrosis With a Multicentre Study on the Incidence, Characteristics, and Treatment of DIOS. Journal of Pediatric Gastroenterology & Nutrition 2010;50:38-42. [DOI: 10.1097/mpg.0b013e3181a6e01d] [Cited by in Crossref: 103] [Cited by in F6Publishing: 28] [Article Influence: 8.6] [Reference Citation Analysis]
20 Chen KG, Zhong P, Zheng W, Beekman JM. Pharmacological analysis of CFTR variants of cystic fibrosis using stem cell-derived organoids. Drug Discov Today 2019;24:2126-38. [PMID: 31173911 DOI: 10.1016/j.drudis.2019.05.029] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
21 Marson FA, Bertuzzo CS, Hortencio TD, Ribeiro JD, Bonadia LC, Ribeiro AF. The ACE gene D/I polymorphism as a modulator of severity of cystic fibrosis. BMC Pulm Med 2012;12:41. [PMID: 22874010 DOI: 10.1186/1471-2466-12-41] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
22 Faria EJ, Faria IC, Ribeiro JD, Ribeiro AF, Hessel G, Bertuzzo CS. Association of MBL2, TGF-beta1 and CD14 gene polymorphisms with lung disease severity in cystic fibrosis. J Bras Pneumol 2009;35:334-42. [PMID: 19466271 DOI: 10.1590/s1806-37132009000400007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
23 Marson FA, Bertuzzo CS, Ribeiro AF, Ribeiro JD. Polymorphisms in the glutathione pathway modulate cystic fibrosis severity: a cross-sectional study. BMC Med Genet 2014;15:27. [PMID: 24593045 DOI: 10.1186/1471-2350-15-27] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
24 Gropman AL, Adams DR. Atypical patterns of inheritance. Semin Pediatr Neurol 2007;14:34-45. [PMID: 17331882 DOI: 10.1016/j.spen.2006.11.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
25 Viel M, Hubert D, Burgel PR, Génin E, Honoré I, Martinez B, Gaitch N, Chapron J, Kanaan R, Dusser D, Girodon E, Bienvenu T. DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis. Clin Respir J 2016;10:777-83. [PMID: 25763772 DOI: 10.1111/crj.12288] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
26 Rana-Díez P, Colón C, Alonso-Fernández JR, Solar A, Barros-Tizón JC, Barros-Casas D, Sirvent J, Carracedo A, Barros F. Three novel mutations in the CFTR gene identified in Galician patients. J Cyst Fibros 2008;7:520-2. [PMID: 18676185 DOI: 10.1016/j.jcf.2008.05.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]